He et al. [44] found that FEZF1-AS1 knockdown in NSCLC reduces the binding ability of EZH2 and LSD1 to the promoter region of E-cadherin, inhibits the transcription of E-cadherin and affects EMT. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.